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yc plays a key role in homeostasis of the skin.
We show that Miz1, which mediates Myc re-
pression of gene expression, is expressed in
the epidermal basal layer. A large percentage of genes
regulated by the Myc–Miz1 complex in keratinocytes
encode proteins involved in cell adhesion, and some, in-
cluding the 
 
 
 
6 and 
 
 
 
1 integrins, are directly bound by
Myc and Miz1 in vivo. Using a Myc mutant deﬁcient in
Miz1 binding (MycV394D), we show that Miz1 is required
for the effects of Myc on keratinocyte responsiveness to
M
 
TGF-
 
 
 
. Myc, but not MycV394D, decreases keratinocyte
adhesion and spreading. In reconstituted epidermis,
Myc induces differentiation and loss of cell polarization
in a Miz1-dependent manner. In vivo, overexpression of
 
 
 
1 integrins restores basal layer polarity and prevents
Myc-induced premature differentiation. Our data show
that regulation of cell adhesion is a major function of
the Myc–Miz1 complex and suggest that it may contrib-
ute to Myc-induced exit from the epidermal stem cell
compartment.
 
Introduction
 
The 
 
c-myc
 
 protooncogene encodes a transcription factor, Myc,
which forms an obligate heterodimeric complex with a partner
protein, Max (Eisenman, 2001; Levens, 2003). The complex
can both activate and repress transcription. It activates tran-
scription upon direct binding to specific DNA sequences,
termed E-boxes, which are found in the promoters of a large
group of Myc-induced genes, including both protein-coding
and ribosomal RNA genes (Oskarsson and Trumpp, 2005). The
Myc–Max complex represses transcription when it is tethered
to DNA via other transcription factors, such as the zinc finger
protein Miz1 (Adhikary and Eilers, 2005).
The ability to bind to and activate transcription from
E-boxes is required for multiple biological functions of Myc
(Amati et al., 1993); however, it is less clear which functions of
Myc require complex formation with Miz1. Using a loss-of-
interaction screen in yeast, we have previously mapped the
Myc–Miz1 interaction surface to the “outside” of the helix-
loop-helix domain (Herold et al., 2002). This analysis identified
a point mutant of Myc (MycV394D) that has lost the ability to
bind to Miz1, but not to Max, in vivo and is not recruited to
Miz1-binding sites on DNA (Herold et al., 2002; Wu et al.,
2003). MycV394D is capable of E-box–dependent activation of
reporter plasmids, but does not repress Miz1-activated transcrip-
tion (Herold et al., 2002). Extensive array analyses showed that
MycV394D is fully able to activate transcription of endogenous
Myc target genes, but fails to repress a large set of genes that are
repressed by wild-type Myc (Adhikary et al., 2003; unpublished
data). Surprisingly, MycV394D induces apoptosis and cell cycle
entry in serum-starved fibroblasts with an efficiency similar to
wild-type Myc (Herold et al., 2002). Furthermore, the mutant is
able to transform primary rat embryo fibroblasts together with an
activated allele of Ras, suggesting that binding to Miz1 is not
required for these properties of Myc (unpublished data).
One group of genes that is repressed by Myc via Miz1 en-
codes the cell cycle inhibitors p15Ink4b (Seoane et al., 2001;
Staller et al., 2001), p21Cip1 (Herold et al., 2002; Seoane et al.,
2002; Wu et al., 2003), and p57Kip2 (Adhikary et al., 2003).
Of these inhibitors, p15Ink4b is induced by TGF-
 
 
 
 and medi-
ates the TGF-
 
 
 
–induced arrest of proliferation (Hannon and
Beach, 1994). A second class of genes that is repressed by Myc
encodes proteins involved in cell–cell adhesion, in the actin
cytoskeleton, and in adhesion to the ECM (Inghirami et al.,
1990; Coller et al., 2000; Frye et al., 2003). Whether Miz1 is
involved in their regulation is unknown.
A tissue in which Myc-mediated repression of gene expres-
sion is important is the epidermis. The epidermis is maintained
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throughout adult life by a stem cell population (Blanpain et al.,
2004). When cells exit from the stem cell compartment, they
undergo a few further rounds of division, during which time
they are known as transit-amplifying cells. Thereafter, they un-
dergo terminal differentiation along several distinct lineages,
forming the interfollicular epidermis, sebaceous gland, and hair
follicle (Niemann and Watt, 2002). Activation of Myc in cul-
tured human epidermal cells stimulates cells to become tran-
sit-amplifying cells and to undergo terminal differentiation
(Gandarillas and Watt, 1997). Activation of Myc in the basal
layer of transgenic mouse epidermis leads to an increase in pro-
liferation, which may reflect the cell’s departure from the stem
cell into the transit-amplifying cell compartment and a stimula-
tion of differentiation into interfollicular epidermis and cells of
the sebaceous gland (Arnold and Watt, 2001; Waikel et al.,
2001; Braun et al., 2003; Frye et al., 2003).
Repression of gene expression by Myc is potentially
important in triggering these events (Frye et al., 2003; Mur-
phy et al., 2005). First, ectopic expression of Myc re-
presses p15in4kb and renders cultured keratinocytes resistant
to growth inhibition by TGF-
 
 
 
 (Alexandrow et al., 1995;
Warner et al., 1999), suggesting a potential mechanism for the
increase in proliferation resulting from Myc activation in vivo
(Cui et al., 1995; Wang et al., 1997, 1999). Second, kerati-
nocyte adhesion to the underlying basement membrane is a
negative regulator of terminal differentiation (Watt, 2002) and
repression of cell adhesion genes by Myc may promote exit
from the stem cell compartment and differentiation by disrupt-
ing adhesive interactions with the local microenvironment
(Arnold and Watt, 2001; Waikel et al., 2001; Frye et al., 2003;
Wilson et al., 2004).
We now show that endogenous Miz1 is highly expressed
in the basal and suprabasal layers of mouse epidermis and that
multiple genes involved in cell–cell and cell–basement mem-
brane adhesion of keratinocytes are regulated by Myc through
binding to Miz1. Our data show that Myc regulates cell adhe-
sion by binding to Miz1 and may help to elucidate how Myc
can regulate the epidermal stem cell compartment.
 
Results
 
Epidermal expression of Miz1 and its 
role in Myc-induced insensitivity to TGF-
 
 
 
In situ hybridization of embryonic day (E)15.5 mouse embryos
has shown that 
 
miz1
 
 mRNA is preferentially expressed in mul-
tiple epithelia, including skin, the olfactory epithelium, and ep-
ithelia of the gastrointestinal tract (Adhikary et al., 2003). To
extend these findings, we stained sections of murine epithelia
with a monoclonal antibody (10E2) that is directed against
Miz1. We observed strong nuclear staining in all epithelia that
we analyzed, including paw skin, back skin, and tongue (Fig. 1,
A–C). In stratified epithelia, nuclear staining was most intense
in basal and immediately suprabasal layers, and the staining in-
tensity declined in more differentiated cell layers (Fig. 1, A–C).
Two controls were performed to ascertain the specificity of
staining: first, no staining was observed in sections lacking the
primary antibody (unpublished data); second, staining was
abolished by preincubation of the antibody with a bacterial
lysate expressing a GST-Miz1 fusion protein, but not by pre-
incubation with an equal amount of nonrecombinant lysate
(Fig. 1, C and D). We conclude that Miz1 is highly expressed
in mouse epithelia.
To analyze the function of Myc and Miz1 in these cells,
we isolated keratinocytes from newborn mice and infected
them with recombinant pBabe-puro retroviruses (Morgenstern
and Land, 1990) encoding either wild-type human Myc or
MycV394D (Introduction; Herold et al., 2002). As a control,
cells were infected with empty pBabe-puro viruses. Infected
cells were selected in puromycin, and pools of resistant cells
were used for further analysis. Immunoblotting showed that
pools of cells infected with either Myc or MycV394D viruses
expressed equally elevated levels of Myc protein, relative to
control-infected cells (Fig. 1 G).
To test whether Myc affects keratinocyte proliferation,
we labeled exponentially growing cells for 1.5 h with BrdU and
determined the percentage of cells incorporating BrdU by im-
munofluorescence (Fig. 1 E). In these experiments, we did not
observe a reproducible difference between the different cell
populations in the absence of TGF-
 
 
 
 (unpublished data). Upon
addition of 100 pM TGF-
 
 
 
, control cells rapidly exited from
the cell cycle (Fig. 1 E). FACscan analysis revealed that addi-
tion of TGF-
 
 
 
 led to an arrest in both the G1 and the G2 phase
of the cell cycle (Fig. 1 F). The response of cells expressing
MycV394D was indistinguishable from that of control infected
cells; in contrast, cells expressing wild-type Myc showed a sig-
nificantly delayed exit from the cell cycle (Fig. 1 E). Surpris-
ingly, even cells expressing wild-type Myc were not com-
pletely resistant to TGF-
 
 
 
, in contrast to what has been
observed in established cell lines (Alexandrow et al., 1995;
Warner et al., 1999). Immunoblotting revealed that addition of
TGF-
 
 
 
 decreased the amount of not only endogenous but also
of the retrovirally expressed Myc proteins; whether this is caused
by enhanced proteolysis or inhibition of translation is currently
unknown (Fig. 1 G). We suggest that this down-regulation
accounts for eventual cell cycle exit, even for cells expressing
wild-type Myc.
Myc and Miz1 have both been implicated in the expres-
sion of the cell cycle inhibitors p15Ink4b and p21Cip1, both of
which can be induced by TGF-
 
 
 
 in different cell types (Hannon
and Beach, 1994; Florenes et al., 1996). Immunoblotting of cell
extracts revealed that addition of TGF-
 
 
 
 had no effect on the
expression of p21Cip1 in primary mouse keratinocytes (Fig.
1 G). In contrast, TGF-
 
 
 
 up-regulated expression of p15Ink4b
in control cells and in cells expressing MycV394D, but not in
cells expressing wild-type Myc. This regulation of p15Ink4b is
in accordance with the altered proliferation behavior of cells
expressing wild-type Myc.
Similarly, an RT-PCR analysis revealed that expression
of Myc, but not of MycV394D, inhibited up-regulation of
 
p15ink4b
 
 mRNA in response to TGF-
 
 
 
 (Fig. 1 H). Analysis of
multiple cell cycle regulatory genes revealed that addition
of TGF-
 
 
 
 suppressed the expression of 
 
ccna2
 
, 
 
cdc6
 
, and 
 
ccne1
 
,
which are genes that are expressed in the S phase of the cell
cycle. Expression of Myc, but not of MycV394D, maintained 
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expression of these genes even in the presence of TGF-
 
 
 
.
Because these genes are regulated by E2F factors, which act
downstream of p15Ink4b, we suggest that their regulation is an
indirect consequence of the regulation of 
 
p15ink4b
 
 mRNA by
Myc. In contrast, TGF-
 
 
 
 had no influence on expression of
cyclin mRNAs expressed in the G1 (with the possible excep-
tion of cyclin D1) and G2 phases of the cell cycle, consistent
with the observation that the addition of TGF-
 
 
 
 led to an arrest
in both the G1 and the G2 phases of the cell cycle (Fig. 1 F).
We also considered the possibility that the differential effects
of Myc and MycV394D might be mediated through another
member of the Myc network of proteins. Therefore, we mea-
sured the expression of 
 
mxd1
 
, 
 
mxd2
 
, 
 
mxd4
 
, 
 
max
 
, 
 
miz1
 
, and 
 
mnt
 
by RT-PCR in these cells (Fig. 1 I). Consistent with earlier
findings, the addition of TGF-
 
 
 
 led to an up-regulation of 
 
mxd
 
gene expression (Werner et al., 2001). Importantly, neither ex-
pression of Myc nor of MycV394D had an effect on expression
of any the tested mRNAs, suggesting that the differential effects
of both proteins on cell proliferation are not indirect conse-
quences of regulation of another Myc network protein.
Finally, we found that the effects were specific for the re-
sponse of keratinocytes to TGF-
 
 
 
 because neither Myc nor
MycV394D had any effect on Ca
 
2
 
 
 
-induced cell cycle exit
or expression of p21Cip1 and p15Ink4b (unpublished data).
Together, the data show that the binding of Myc to Miz1 is
required for inhibition of p15ink4b expression and for main-
taining keratinocytes in cycle in the presence of TGF-
 
 
 
.
 
Identification of Myc–Miz1-responsive 
genes
 
To identify epidermal genes that are regulated by Myc via
binding to Miz1, we performed a microarray analysis of RNA
isolated from either control keratinocytes or from cells express-
ing Myc or MycV394D both before and 12 h after addition of
TGF-
 
 
 
. For this analysis, we used a 22,500 complementary
DNA (cDNA) array. The analysis identified 160 genes, which
were induced by twofold or more upon the addition of TGF-
 
 
 
to control infected cells. Comparison of the expression of these
genes to cells expressing either wild-type Myc or MycV394D
revealed three distinct expression profiles (Fig. 2 A and
 
 
 
Table
S1,
 
 
 
available at http://www.jcb.org/content/full/jcb.200506057/
DC1). The induction of the first class of genes (
 
n
 
 
 
 
 
 54), ex-
emplified by 
 
foxo1a
 
, was unaffected by either Myc or
MycV394D, confirming previous suggestions that Myc does
not generally inhibit signal transduction by TGF-
 
 
 
 (Fig. 2;
Seoane et al., 2001). A second group of genes (
 
n
 
 
 
 
 
 49), includ-
ing 
 
Imo1
 
, was inhibited by expression of both Myc and
MycV394D (Fig. 2 A). Finally, we found 67 genes, including
 
Igals1
 
, which were induced by TGF-
 
 
 
 in control cells and in
cells expressing MycV394D, but not in cells expressing wild-
type Myc, arguing that they were repressed by Myc via binding
to Miz1 (Fig. 2 A). These results were confirmed by a second
array experiment from independently generated cell pools (un-
published data) and by an RT-PCR experiment for several of
the differentially regulated genes (Fig. 2 B).
Figure 1. Role of Miz1 in the response of keratinocytes
to TGF- . (A–D) Immunohistochemical staining of Miz1.
Formalin-fixed and paraffin-embedded mouse tissue sec-
tions from paw skin (A), back skin (B), or tongue (C and D)
were stained using the  -Miz1 antibody 10E2 (A and B)
and 10E2 preincubated with a bacterial lysate (C) or pre-
incubated with a bacterial lysate expressing a GST-Miz1
fusion protein (D). Pictures were taken using a microscope
(Axiovert; Carl Zeiss MicroImaging, Inc.) equipped with a
MC100 SPOT camera and a 32  lens with a numerical
aperture of 0.4. Bars, 40  m. (E) Proliferation of primary
murine keratinocytes overexpressing either Myc or
MycV394D. Infected keratinocytes were incubated with
100 pM TGF-  for 0, 12, or 24 h. Cells were labeled
with BrdU for 1.5 h before the end of incubation. The per-
centage of BrdU-positive cells was determined by indirect
immunofluorescence. (F) Two-dimensional FACscan analy-
sis of primary murine keratinocytes before and after incu-
bation with 100 pM TGF-  for 12 h. (top) The results of
cells stained with BrdU and propidium iodide before and
after incubation with TGF- ; (bottom) a quantitative repre-
sentation of the results. (G) Immunoblots of extracts from
keratinocytes either before or 12 h after addition of TGF- 
using the indicated antibodies. The asterisk in the bottom
panel indicates a nonspecific cross-reactive band. Endog-
enous Myc uses both an AUG and a CUG start codon lo-
cated further upstream, so it migrates as two separate
bands on SDS gels (Hann et al., 1988). The CUG codon
is deleted in the retroviral vectors used to overexpress Myc
and MycV394D, so the exogenous protein migrates as a
single band. (H) RT-PCR analysis of cell cycle genes. RNA
was isolated from either control primary murine kerati-
nocytes or cells overexpressing either Myc or MycV394D
as indicated.   indicates that the keratinocytes were incu-
bated with 100 pM TGF-  for 12 h. (I) RT-PCR analysis of
genes encoding proteins of the Myc network. RNA sam-
ples were identical to those shown in H. 
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Functional annotation revealed that almost 40% of the
genes in this latter group encoded components of the ECM
(e.g., tenascin c), integrin ECM receptors (e.g., integrins sub-
units 
 
 
 
4 and 
 
 
 
6), and proteins involved in cell–cell interactions
(e.g., 
 
 
 
-catenin; Fig. 2 C). Our previous work had shown that
Myc represses a group of functionally similar genes in mouse
skin in vivo (Frye et al., 2003). In this analysis, we had also
identified genes encoding proteins of the cytoskeleton as targets
for repression by Myc, some of which are not present on the
array used in the current analysis. Thus, we performed addi-
tional RT-PCR experiments and found that at least one of these
genes, 
 
adducin
 
, is repressed by wild-type Myc, but not by
MycV394D (Fig. 2 B). Finally, the group included two collagen
genes, which were expressed at low levels in the isolated kerati-
nocytes although they are predominantly expressed in the dermis
in vivo (
 
col1a2
 
 and 
 
col5a2
 
). The results suggest that binding of
Myc to Miz1 is required for repression of a set of genes that
regulate the adhesive properties of mouse keratinocytes.
To test whether any of these genes are direct targets of
Myc and Miz1, we performed chromatin-immunoprecipitation
experiments. Because the available antibodies do not precipi-
tate mouse Miz1, we used chromatin isolated from HeLa cells
for these experiments. Chromatin was prepared and precipi-
tated with secondary reagents alone, with control antibodies, or
with antibodies directed against Myc or Miz1, respectively
(Fig. 3 A). The known binding sites for Miz1 are close to the
transcription start sites (Staller et al., 2001; Ziegelbauer et al.,
2001); therefore, we performed PCR using primer pairs that
span 1 kb around the transcription start sites of the indicated
genes. In vivo binding of Miz1 and Myc was detected at the
start sites of the integrin 
 
 
 
6 (
 
ITGA6
 
), 
 
 
 
1 (
 
ITGB1
 
), and 
 
 
 
4
(
 
ITGB4
 
) genes, as well as to procollagen I 
 
 
 
2 (
 
COL1A2
 
) and
galectin-1 (
 
LGALS1
 
) genes (Fig. 3 A). To demonstrate speci-
ficity of binding, we used target genes that are activated by
Myc and detected binding of Myc, but not of Miz1, to se-
quences surrounding E-box elements in the nucleolin (
 
NCL
 
),
proliferating cell nuclear antigen (
 
PCNA
 
), and prothymosin-
 
 
 
genes (
 
PTMA
 
; Fig. 3 A). As a negative control, we used prim-
ers surrounding the start site of the 
 
 
 
-tubulin (
 
TUBB
 
) gene,
which is regulated neither by Myc nor by Miz1. To exclude the
possibility that binding was restricted to HeLa cells, we re-
peated the experiment for several of the genes using chromatin
from an established human keratinocyte line (HaCaT) and ob-
tained identical results (Fig. 3 B). We conclude that at least
some of the genes regulating cell adhesion in keratinocytes are
direct target genes of Myc and Miz1.
 
Role of Miz1 in Myc-induced reduction in 
cell adhesion, spreading, and motility
 
To confirm the differential effects of Myc and MycV394D at the
protein level, primary human epidermal keratinocytes were
transduced with retroviral vectors encoding inducible alleles
of Myc and MycV394D (termed MycER and MycV394DER,
Figure 2. Identification of epidermal target genes of Myc and Miz1.
(A) Graphical representation of expression of different groups of genes
upon incubation of keratinocytes with 100 pM TGF-  for 12 h. The plots
show the fold induction of a representative gene by TGF-  in the indicated
cells. (B) RT-PCR analysis showing expression levels of several genes that
are differentially regulated by Myc and MycV394D. (C) Functional anno-
tation of the genes shown in B.   and   indicate whether the gene was
present in the original array.
Figure 3. ChIP experiments demonstrating in vivo binding of Myc and
Miz1 to cell adhesion genes. (A) HeLa cells were fixed and chromatin was
immunoprecipitated prepared using the indicated antibodies or secondary
reagents alone (no antibody). For each gene, primers surrounding the
transcription start site or the Myc-bound E-box sequence were used for the
analysis. Input represents the input control. (B) Identical experiment using
chromatin isolated from a human keratinocyte cell line (HaCaT). 
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respectively) or, as a control, the empty vector (pBabe). As pre-
viously reported (Gandarillas and Watt, 1997; Frye et al., 2003),
cell surface levels of 
 
 
 
1 and 
 
 6 integrins decreased upon activa-
tion of MycER with 4-hydroxy-tamoxifen (4-OHT; Fig. 4, A
and B). In contrast, when MycV394DER was activated,  6
integrin levels increased relative to the empty vector control cells
(Fig. 4 A) and  1 integrin levels remained unchanged (Fig. 4 B).
In addition to reducing integrin expression, Myc impairs
keratinocyte spreading and migration and this correlates with
decreased expression of components of the actin cytoskeleton
(Frye et al., 2003). Immunoblotting showed that activation
of MycER led to decreased galectin-1 and adducin levels,
whereas activation of MycV394D had either no or a smaller
effect (Fig. 4 C). Activation of either Myc or MycV394D re-
sulted in increased expression of nucleolin, a known target for
transactivation by Myc (Fig. 4 C; Greasley et al., 2000). Con-
sistent with these observations, chromatin immunoprecipita-
tions (ChIPs) showed that MycER, but not MycV394DER,
bound to the start site of both  1 and  6 integrin genes in vivo
in these cells; in contrast, both MycER and MycV394DER
bound to the E-box of the nucleolin promoter (Fig. 4 D). These
results are consistent with the expression array of primary
mouse keratinocytes and suggest that Myc represses expression
of integrins ( 6,  4, and  1), galectin-1, and adducin through
binding to Miz1, whereas transactivation of E-box element
genes is not dependent on Miz1.
To assess the effects of these alterations on ECM adhe-
sion, we measured the spreading of infected keratinocytes on
collagen-coated dishes (Fig. 5). When plated in serum free me-
dium (FAD), both control keratinocytes and keratinocytes ex-
pressing MycV394DER spread extensively (Fig. 5, A and B).
In contrast, cells expressing wild-type Myc were significantly
less spread out (Fig. 5, A and B). As previously reported, EGF
reduced spreading of control keratinocytes (Fig. 5, A and B;
Haase et al., 2003). In contrast, spreading of keratinocytes
expressing MycV394DER was not reduced by the addition
of EGF (Fig. 5, A and B, FAD EGF), suggesting that
MycV394DER may act as a dominant-negative inhibitor of
EGF-induced cell contraction.
Myc activation inhibits cell motility and wound healing
in vivo and in vitro (Waikel et al., 2001; Frye et al., 2003). To
analyze whether MycV394DER impairs motility in kerati-
nocytes, we performed motility assays using time-lapse mi-
croscopy. Human keratinocytes were pretreated with 4-OHT,
plated on collagen-coated dishes and filmed for 36 h. Sur-
prisingly, keratinocytes expressing either MycV394DER or
MycER showed a similar reduction in motility, relative to con-
trol cells (Videos 1–3, available at http://www.jcb.org/content/
full/jcb.200506057/DC1). Whereas the reduced motility of
MycER cells correlated with decreased spreading and lamelli-
podia formation, cells expressing MycV394DER were more
highly spread than control cells (Fig. 5 C). It is likely that the
reduced motility of keratinocytes expressing MycV394DER is
attributable, at least in part, to the increased expression of
 6 4, relative to control cells (Palecek et al., 1997). EGF is
known to stimulate keratinocyte motility (Haase et al., 2003)
and the reduced motility of MycV394D-expressing cells may
also reflect their inability to contract when stimulated with
EGF (Fig. 5, A and B).
Expression of integrin  1 has been linked to exit from the
stem cell compartment (Gandarillas et al., 2000; Waikel et al.,
2001). To test whether Miz1 might have a role in Myc-induced
exit from the stem cell compartment, we measured the prolifer-
ative potential of individual keratinocytes in a clonogenic assay
(Fig. 5 D). Consistent with earlier observations (Gandarillas
and Watt, 1997), expression of MycER resulted in a reduced
colony number and a higher proportion of abortive colonies,
suggesting that Myc promotes exit from the stem cell compart-
ment in vitro. In contrast, expression of MycV394DER re-
sulted in a higher number of colonies and a higher proportion
of proliferative cells, relative to control infections. These find-
ings are consistent with the differences in regulation of integrin
gene expression and suggest that Miz1 may have a role in Myc-
induced exit from the stem cell compartment in vivo.
Role of Miz1 in Myc-induced epidermal 
proliferation and terminal differentiation
In skin, proliferating keratinocytes are in contact with the base-
ment membrane, and disruption of adhesion to the basement
membrane inhibits proliferation and promotes terminal differ-
Figure 4. Comparison of the effects of MycER and MycV394DER activation
on expression of proteins involved in keratinocyte adhesion. In all experi-
ments, 200 nM 4-OHT was added to all cultures 5 d before harvesting.
(A and B) Flow cytometry of cells labeled with antibodies to  6 (A) or  1
(B) integrin subunits. Note that the analysis was performed on cell pools.
The heterogeneity in  6 expression most likely results from somewhat vary-
ing levels of Myc expression in individual cells. (C) Immunoblots probed
with antibodies to the indicated proteins. (D) ChIPs demonstrating binding
of Myc but not of MycV394D to the start sites of the integrin  1 and  6
genes in vivo. Chromatin from human keratinocytes infected with the indi-
cated viruses was precipitated with control or  -Myc antibodies. For inte-
grins  1 and  6, primers surrounding the transcription start site were used
and, for nucleolin, primers surrounding the Myc-bound E-box sequence
were used for the analysis.JCB • VOLUME 172 • NUMBER 1 • 2006 144
entiation (Watt, 2002). In vivo, the activation of MycER in
cells of the basal layer and their progeny leads to the appearance
of terminally differentiated cells in the basal layer of interfollic-
ular epidermis, potentially because of disrupted cell adhesion
to the basement membrane (Arnold and Watt, 2001). Interfolli-
cular epidermis can be reconstituted in culture by growing human
epidermal cells on de-epidermized dermis (DED) obtained
from human breast skin (Fig. 6). Therefore, we used DED cul-
tures to compare the effects of Myc and MycV394D on terminal
differentiation (Fig. 6). Stratification of control keratinocytes
on DEDs resembled that of normal epidermis in vivo, with dis-
tinct basal, spinous, granular, and cornified layers (Fig. 6 A).
The epidermis formed by keratinocytes infected with MycER
in the presence of 4-OHT was more disorganized, with a strik-
ing accumulation of cornified layers (Fig. 6, A and B). DEDs
reconstituted with keratinocytes infected with MycV394DER
showed a similar accumulation of the differentiated layers to
MycER (Fig. 6 C). In contrast, the morphology of the basal
layer of epidermis reconstituted with keratinocytes expressing
MycER or MycV394DER could easily be distinguished. The
basal layer of epidermis reconstituted with wild-type Myc was
loosely packed and disorganized, whereas the basal layer of
MycV394D-expressing epidermis was densely packed, with
highly polarized cells in contact with the basal lamina (Fig. 6,
D–F). Staining with antibodies directed against E-cadherin
(Fig. 6, J–L) and  -tubulin (unpublished data) showed that
cells in the basal layer of DEDs reconstituted with control kera-
tinocytes or cells expressing MycV394DER appeared more po-
larized compared with cells expressing MycER. Staining with
antibodies directed against Myc clearly revealed the presence
of the ectopically expressed MycER and MycV394DER proteins
and established that the observed differences in morphology
were not caused by differences in expression of both proteins
(Fig. 6, M–O).
To analyze the effects on cellular differentiation, we
stained sections with antibodies against involucrin, a marker
of terminal differentiation (Gandarillas and Watt, 1997).
DEDs reconstituted with keratinocytes infected with MycER
show increased numbers of involucrin-positive cells in the
basal layer, indicating premature differentiation (Fig. 6, G and H;
Gandarillas and Watt, 1997). In contrast, expression of involu-
crin in DEDs reconstituted with MycV394DER was restricted
to the suprabasal layers, similar to DEDs reconstituted with
control keratinocytes, strongly suggesting that induction of
premature differentiation by Myc requires binding to Miz1
(Fig. 6 I). We conclude that Myc binding to Miz1 is required
for premature terminal differentiation and disorganization of
the basal layer.
The lack of premature differentiation of human kerati-
nocytes expressing MycV394D suggested that binding to
Miz1 is required for this effect of Myc. To provide direct evi-
dence that repression of integrin expression contributed to a
phenotype of mice in which Myc is activated in the epidermal
basal layer, we crossed K14MycER mice with mice that ex-
press the human  1 integrin subunit under the control of the
K14 promoter (K14 1 mice; Fig. 7). We chose  1 integrin
for this experiment because both Myc and Miz1 bind to its
promoter in vivo and because expression of this integrin has
been linked to exit from the stem cell compartment in cul-
tured human keratinocytes (Watt, 2002). The phenotype of
K14 1 mice was indistinguishable from wild-type mice (Fig. 7
A, B, E, F, I, J, M, N, Q, and R). In the presence of the  1
Figure 5. Comparison of the effects of MycER and
MycV394DER activation on keratinocyte spreading and motility.
200 nM 4-OHT was added to all cultures 5 d before harvest-
ing. (A and B) Spreading of cells transduced with pBabe
(control), MycER, or MycV394DER in the presence or ab-
sence of EGF. (A) Quantitation of spreading area per cell.
(B) Representative fields of cells labeled with rhodamine-
conjugated phalloidin. Pictures were taken using a micro-
scope with a 20  lens with a numerical aperture of 0.50.
Bar, 100  m. (C) Representative detailed fields of a frame
from the time-lapse recording (Videos 1–3, available at
http://www.jcb.org/content/full/jcb.200506057/DC1).
Pictures were taken using IMT1 or IMT2 inverted microscopes
(Olympus) equipped with monochrome charge-coupled device
cameras and a 10  lens with a numerical aperture of 0.25.
(D and E) Clonogenic assays of human keratinocytes infected
with pBabe (control), MycER, or MycV394DER. Cells were
seeded at clonal density and colonies were stained 2 wk
later. (D) The absolute number of growing and abortive colo-
nies after plating of 10
4 cells per 35-mm dish. (E) Representa-
tive dishes from the experiment shown in D.MIZ1 FUNCTION IN KERATINOCYTES • GEBHARDT ET AL. 145
integrin the Myc-induced increase in differentiated cells of
the sebaceous gland was reduced (Fig. 7, G and H), but the
sebaceous glands were not entirely normal because the number
of proliferating cells at their periphery was increased (Fig. 7,
G and H). The  1 integrin did not prevent Myc-induced pro-
liferation and indeed Ki67 labeling was slightly higher in the
double transgenic mice than in K14MycER mice (Fig. 7, I–L).
Importantly, however, transgenic expression of  1 integrin
resulted in a normalization of keratin 10 and of involucrin ex-
pression and strongly reduced the number of cells in the basal
membrane expressing either keratin 10 or involucrin (Fig. 7,
M–P and Q–T); in addition, expression of the  1 transgene
restored polarity to the basal layer (Fig. 7, C and D). In con-
trast, overexpression of  1 integrins did not prevent the delay
in wound closure resulting from Myc activation (Fig. 7, U–X;
and not depicted). We conclude that Myc–Miz1-mediated
down-regulation of integrin expression is responsible for the
loss of polarity and premature differentiation of cells in the
basal layer of the epidermis.
Discussion
Several previous observations have linked the Myc oncoprotein
to the control of cell adhesion. In particular, down-regulation
of several integrins is observed in different cell types express-
ing either deregulated (c-)Myc or N-Myc (Inghirami et al.,
1990; Judware and Culp, 1995; Gandarillas and Watt, 1997;
Coller et al., 2000; Frye et al., 2003). Conversely, genetic ab-
lation of endogenous (c-)Myc up-regulates multiple genes
encoding cell adhesion proteins, arguing that regulation of cell
adhesion by Myc is a physiological function during normal
development (Wilson et al., 2004).
Figure 6. Effects of MycER and MycV394DER on epidermal differ-
entiation in DED cultures. Human keratinocytes were transduced with
pBabe (A, D, G, J, M, and P), MycER (B, E, H, K, N, and Q), or
MycV394DER (C, F, I, L, O, and R). Cultures were grown in the pres-
ence of 200 nM 4-OHT. (A–F) Hematoxylin and eosin staining. (G–I)
Immunostaining for involucrin (red). (J–L) Immunostaining for E-cadherin
(green). (G–L) DAPI counterstaining (blue). (M–O) Immunostaining
for Myc. (P–R) Control staining with secondary reagents only. Pictures
A–L were taken using a confocal microscope (Carl Zeiss Micro-
Imaging, Inc.) with a 25  lens with a numerical aperture of 0.80.
Pictures M–R were taken using an Axiovert microscope equipped
with a MC100 SPOT camera and a 32  lens with a numerical
aperture of 0.4. Bars: (A–C) 100  m; (D–R) 50  m.
Figure 7. Effect of constitutive  1 integrin
expression on the epidermal phenotype of
mice with activated Myc. Dorsal epidermis
was either unwounded (A–T) or wounded and
analyzed 7 d later, after wound closure (U–X).
(A–H and U–X) Hematoxylin and eosin stain-
ing; (I–L) immunostaining for Ki67; (M–P) im-
munostaining for keratin 10 (green) with DAPI
nuclear counterstain; (Q–T) immunostaining
for involucrin (green) with DAPI nuclear counter-
stain. Mice were either K14 1 (B, F, J, N, R,
and V) or K14MycER (C, G, K, O, S, and W)
single or double (D, H, L, P, T, and X) trans-
genics or wild-type littermate controls (A, E, I,
M, Q, and U). Pictures were taken using a
confocal microscope with a 25  lens with a
numerical aperture of 0.80. Bars, 100  m.JCB • VOLUME 172 • NUMBER 1 • 2006 146
We show here that in keratinocytes regulation of cell ad-
hesion by Myc occurs through the Myc–Miz1 complex. This
notion is supported by four main arguments. First, endogenous
Miz1 is highly expressed in the basal layer of multiple epithe-
lia. Second, a microarray analysis identifies multiple genes that
encode proteins of the ECM, cell surface receptors for ECM
proteins, and proteins that are involved in cell–cell or cell–ma-
trix adhesion as genes that are repressed by wild-type Myc, but
not by MycV394D, a point mutant of Myc that is unable to
bind to Miz1 (Herold et al., 2002). Third, ChIP reveals that
Myc and Miz1 bind in vivo to the start sites of the genes we
tested. In particular, the integrins  6,  1, and  4, which medi-
ate the adhesion of keratinocytes to the basement membrane
and which are critically required for the integrity of the epider-
mis in vivo, are direct target genes of both Myc and Miz1.
These findings are consistent with a previous study demon-
strating in vivo binding of Miz1 to the start site of the integrin
 2 promoter (Ziegelbauer et al., 2001). Fourth, spreading of
keratinocytes in vitro on collagen, as a measure of  2 1-medi-
ated adhesion to the ECM, is inhibited by wild-type Myc, but
not MycV394D. Together, our data demonstrate that regulation
of keratinocyte adhesion is a direct function of Myc that is ex-
erted through binding to Miz1.
In epidermis, cell adhesion is tightly linked to the control
of terminal differentiation and departure from the cell cycle
(for review see Watt, 2002). Activation of Myc in keratinocytes
results in exit from the stem cell into the transit-amplifying com-
partment, which is associated with an increase in proliferation
and stimulation of sebocyte and interfollicular epidermal dif-
ferentiation in vivo (Arnold and Watt, 2001; Waikel et al.,
2001). Comparison of epidermis reconstituted on DED by
Myc- or MycV394D-expressing keratinocytes and of trans-
genic epidermis, in which Myc is activated alone or in combi-
nation with  1 integrin overexpression, allows us to dissect the
different roles of Myc in this process. The disruption of the
basal layer and premature interfollicular epidermal differentia-
tion can be attributed to Miz1-dependent repression of gene ex-
pression by Myc. In contrast, introducing the V394D mutation
in Myc or overexpressing  1 integrin does not normalize the
increase in sebocyte differentiation, arguing that repression of
integrin expression is not required for these events.
These data imply that the interaction between Myc and
Miz1 must be tightly controlled during normal skin differentia-
tion; in particular, expression levels of endogenous Myc are
high in basal layers, where we suggest that Miz1 is active to
drive integrin expression. Although we do not know how ex-
actly the interaction between Myc and Miz1 is regulated, we
have recently characterized an E3-ligase, HectH9, that ubiquit-
inates and activates free Myc–Max complexes, but not Myc
bound to Miz1, through K63-linked ubiquitination, suggesting
that ubiquitination by HectH9 may have a role in regulating the
interaction (Adhikary et al., 2005).
It should be noted that elevated expression of integrins
and of multiple TGF- –induced transcripts are markers of stem
cells in human interfollicular epidermis and in human and
mouse hair follicles (Tumbar et al., 2004). Down modulation of
adhesive interactions by Myc has been suggested to promote
exit of both epidermal and hematopoietic stem cells from the
stem cell niche (Waikel et al., 2001; Frye et al., 2003; Wilson
et al., 2004; Murphy et al., 2005). Our results suggest that the
interaction of Myc with Miz1 may play an important role in
this process.
Finally, Myc is a classic protooncogene and it is worth
noting that disruption of cell adhesion may also be critical for
the oncogenic effects of Myc (Guo and Giancotti, 2004). For
example, activation of Myc not only promotes growth and
proliferation but also induces highly invasive tumors in a
transgenic model of pancreatic tumorigenesis using the insulin
promoter (Pelengaris et al., 2002). In addition, amplification of
MYC is closely correlated with the progression from the in situ
to the invasive stage in human breast carcinomas (Robanus-
Maandag et al., 2003). Therefore, we suggest that disruption of
cell adhesion by Myc through Miz1 could contribute to the
genesis of a wide range of tumors; genetic models to address
this hypothesis are currently being generated.
Materials and methods
Cell culture, transfection, and retroviral infection
1 d postpartum Friend leukemia virus B (National Institutes of Health
[NIH]) mice were killed by decapitation, and keratinocytes were isolated
according to Hager et al. (1999). For cell culture medium, we used Eagle’s
minimum essential medium with Earle’s BSS without CaCl2 (Cambrex),
supplemented with 10
 10 M choleratoxin (Calbiochem), 0.4  g/ml hy-
drocortisone (Sigma-Aldrich), 0.75 mM aminoguanidine nitrate (Sigma-
Aldrich), and 2 ng/ml EGF (ICN Biomedicals) and with antibiotic and
antimycotic agents (10,000 U/ml penicillin, 10,000  g/ml streptomy-
cin, and 25  g/ml amphotericin B; Invitrogen). FCS (Sigma-Aldrich) was
decalcified using Chelex 100 (Bio-Rad Laboratories) and was added in
a concentration of 8% to the medium. This essentially calcium-free me-
dium was then substituted with 60  M CaCl2. To obtain conditioned me-
dium, we cultivated primary dermal fibroblasts in this medium for 48 h.
Isolated keratinocytes were cultivated at 37 C in a humidified chamber
equilibrated with 5% CO2, using equal parts of conditioned and uncon-
ditioned medium.
Cells were plated at 10
5 cells/cm
2 on collagen IV (Fluka)–coated
plastic dishes (1  g/cm
2) and cultured for 2–3 d until they reached 60–
80% confluency. Keratinocytes were infected with retroviral supernatants
for 7 h, rinsed two times with PBS, and placed in keratinocyte medium.
After 2 d, selection with 1  g/ml puromycin (Sigma-Aldrich) was started.
2.5 d later, cells were incubated with 100 pM TGF- 1 (Sigma-Aldrich) for
12 or 24 h.
J2-3T3 cells were cultured in DME containing 10% donor calf serum.
Primary human keratinocytes were isolated from neonatal foreskin and cul-
tured in the presence of a feeder layer of J2-3T3 cells in FAD medium (one
part Ham’s F12 medium, three parts DME, and 1.8   10
 4 M adenine)
supplemented with 10% FCS and a cocktail of 0.5  g/ml hydrocortisone,
5  g/ml insulin, 10
 10 M cholera toxin, and 10 ng/ml EGF, as described
previously (Gandarillas and Watt, 1997). Keratinocytes were cultured on
a dermal equivalent of dead DED from adult breast skin (Rikimaru et al.,
1997). Fourth or fifth passage keratinocytes were seeded on DED and
grown at the air–liquid interface for 14 d.
Retroviral supernatants were generated by transient transfection of
Phoenix packaging cells and stable infection of AM12 cells. Keratinocytes
were infected by coculture with retroviral producer cells as described previ-
ously (Gandarillas and Watt, 1997) and used within one or two passages
after infection. Activation of the steroid-inducible constructs was performed
by adding 200 nM 4-OHT (Sigma-Aldrich) to the culture medium.
RNA isolation and preamplification
Total cellular RNA was isolated with the RNAeasy reagent (QIAGEN) and
a subsequent DNase digestion was included. RNA was amplified with
MessageAmp RNA amplification kit (Ambion) and labeled with CyScribe
cDNA post-labeling kit (GE Healthcare). All procedures were performed
according to the manufacturer’s instructions. RNA quality was controlled
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Microarray analysis
Each experiment was performed as a sandwich hybridization, i.e., instead
of a coverslip, a second microarray slide was used. This provides a repli-
cated measurement for each hybridization that can be used for quality con-
trol and to reduce technical variability. Spot intensities were extracted from
a scanned image with ImaGene 3.0 (BioDiscovery, Inc.). Software parame-
ters like “signal range” or “spot detection threshold” were optimized for
maximum reproducibility before the image analysis of our experiment. For
each spot, median signal and background intensities for both channels
were obtained. To account for spot differences, the background-corrected
ratio of the two channels were calculated and log2 transformed. To balance
the fluorescence intensities for the two dyes, as well as to allow for compari-
son of expression levels across experiments, the raw data was standard-
ized. We used a spatial- and intensity-dependent standardization to correct
for inherent bias on each chip (the lowess scatter-plot). To compare different
cell types and conditions, the replicated chips were averaged. To find differ-
ently expressed genes, the differences between different cell lines with and
without TGF-  treatment was calculated for each gene.
RT-PCR
First-strand cDNAs of amplified RNA were synthesized with M-MLV Re-
verse Transcriptase (Invitrogen) and random hexamer primers (Promega).
For each PCR amplification, aliquots were taken after different cycles to
determine the linear range of the amplification. Primer sequences are
available in Table S2 (available at http://www.jcb.org/content/full/
jcb.200506057/DC1).
ChIP
ChIP assays were performed as described previously (Bouchard et al.,
2001) using the following antibodies: anti-Miz1 (C-19), anti–c-Myc (N-262),
and anti-Gadd45 (H-165). All were obtained from Santa Cruz Biotechnol-
ogy, Inc. Immunoprecipitated DNA was amplified by PCR using primers
specific for the transcription start site of the galectin, procollagen I 2, inte-
grin  6, and integrin  4 promoters and for the E-boxes of pcna, nucleolin,
prothymosin- , and  -tubulin promoters. For each promoter, PCR reactions
were performed with a different number of cycles or with dilution series of
input DNA to determine the linear range of the amplification; all results
shown fall within this range. Primer sequences are available in Table S2.
Immunohistochemistry
Tissue samples were either fixed in 4% PBS-buffered formalin and embed-
ded in paraffin or were placed in optimal cutting temperature compound
(Miles Scientific) and frozen in isopentane surface cooled with liquid nitro-
gen. 5- m sections were used for hematoxylin and eosin staining, immu-
nohistochemistry, and immunofluorescence. Paraffin sections of tissue sam-
ples were microwaved in antigen retrieval solution (10 mM citrate buffer,
pH 6) for 15 min in a microwave oven. After being cooled to room tem-
perature, slides were washed in distilled water, incubated in 3% H2O2 for
10 min, and washed three times in PBS. After a 45-min incubation in 10%
normal goat serum in PBS, the undiluted 10E2 antibody was applied and
slides were incubated overnight at 4 C. Slides were washed three times in
PBS and incubated for 30 min at room temperature with a biotinylated
secondary antibody (goat anti–mouse immunoglobulin G; DakoCytoma-
tion) at a 1:500 dilution. After three washes in PBS, a streptavidin–biotin–
peroxidase complex (DakoCytomation) was applied for 30 min at room
temperature. Slides were washed three times in PBS again and incubated
with 3-amino-9-ethylcarbazole (Zymed Laboratories) at room temperature
under microscopic control. After a final wash in distilled water, slides
were mounted in Mowiol (Hoechst).
Frozen tissue sections and cultivated cells were fixed with 2% para-
formaldehyde for 10 min and, if necessary, treated for 5 min with 0.4%
Triton X-100. After blocking with 10% FCS in PBS, sections were incu-
bated for 1 h with the antibodies diluted in 10% FCS in PBS. Secondary
antibodies were conjugated with Alexa Fluor 488 or 594 (Invitrogen).
Antibodies against the following proteins were used: Miz1 (10E2), In-
volucrin (ERLI-3), E-cadherin (HECD-1), and  -tubulin (DM1A; Sigma-Aldrich).
Flow cytometry
Primary human keratinocytes were labeled with  6 integrin antibody conju-
gated to FITC (BD Biosciences) or anti– 1 integrin (MB1.2; Carroll et al.,
1995) for 30 min at room temperature with rotation. Cells were then ana-
lyzed using a FACscalibur II sorter and Cell Quest FACS analysis system
(BD Biosciences). For cell cycle analysis, keratinocytes were harvested and
washed with PBS, fixed in 70% ethanol on ice for 30 min, washed twice
with PBS, and treated with 100  g/ml RNase. After staining with 50  g/ml
propidium iodide, the DNA content was analyzed by flow cytometry.
Proliferation assays
Primary murine keratinocytes were plated on coated 24-well dishes and cul-
tured as described in Cell culture, transfection, and retroviral infection. After
incubation with TGF-  for 0, 12, or 24 h, BrdU was supplied to the kera-
tinocyte medium 1.5 h before the termination of incubation. Keratinocytes
were fixed in 4% PBS-buffered paraformaldehyde for 30 min at room tem-
perature, washed three times in PBS, and incubated for 10 min in 10 mg/ml
glycine. After three washes in PBS, cells were incubated with 3% H2O2 in
methanol for 20 min at room temperature and washed three times in both
PBS and PBS/0.1% Tween. 2 M HCl/0.1% Triton X-100 was applied for 5
min at room temperature, and then cells were washed three times in PBS
and blocked in 3% BSA/0.1% Tween in PBS for 45 min at room tempera-
ture. The BrdU antibody (DakoCytomation; diluted 1:50 in 3% BSA/0.1%
Tween) was applied and cells were incubated over night at 4 C. Further
staining was performed as described as in Immunohistochemistry. Cells
were counterstained with DAPI. To obtain the percentage of BrdU-labeled
cells, a minimum of 3,500 cells from each sample were counted.
Spreading, motility, and colony-forming assays
Keratinocytes were cultured in complete FAD medium and treated with
100 nM 4-OHT for 24 h. Cells were harvested, washed twice with PBS,
and cultured on collagen-coated dishes for 3 h in FAD medium (without se-
rum and growth factors) or in FAD medium containing 10 ng/ml EGF
(PeproTech; FAD   EGF). Cells were washed three times with PBS, fixed
with 4% paraformaldehyde, and stained with phalloidin (Sigma-Aldrich).
200 randomly selected cells per treatment group were examined by mi-
croscopy. Photographs were taken using a digital camera (model Magna-
Fire v1.0; Optronics). The spreading area of each cell was measured in
pixels using NIH Image software, version 1.58. Median values and stan-
dard errors were estimated using Excel (Microsoft).
To analyze motility, cells were cultured in complete FAD medium and
incubated with 4-OHT for 24 h, harvested, and cultured on collagen-coated
dishes in the presence of 4-OHT (Becton Dickinson). The cells were kept hu-
midified at 37 C with 5% CO2 and videotaped for 48 h. Frames were
taken every 4 min using inverted microscopes (models IMT1 or IMT2; Olym-
pus) driven by Broadcast Animation Controllers (BAC 900; EOS Electronics
[AV], Ltd.) and fitted with monochrome charge-coupled device cameras and
video recorders (models M370 CE and PVW-2800P, respectively; Sony).
Recordings were digitized and the sequence of all frames was run on a PC.
For the clonogenicity assays, retrovirally infected keratinocytes
were treated with 4-OHT for 3 d. The cells were harvested and 10
4 kerati-
nocytes were plated per 35-mm dish coated with type IV collagen (Becton
Dickinson). Mitotically inactivated J2-3T3 feeders were added; after 10
min, the dish was rinsed with PBS to remove nonadherent cells and then
cultured for 14 d. Cells were fixed with 4% paraformaldehyde and
stained with 1% rhodamine B and 1% Nile blue (BDH). Colonies were
viewed using a dissection microscope (model 3DZ; Wild) and scored as
described previously (Jones and Watt, 1993).
Transgenic mice
The K14 1 transgene cassette was generated by inserting the human  1 in-
tegrin subunit cDNA (Carroll et al., 1995) into the K14 expression cassette
(gift of E. Fuchs, The Rockefeller University, New York, NY) previously used
to generate K14MycER transgenic mice (Arnold and Watt, 2001). The
K14 1 transgene was injected into the male pronucleus of day 1 fertilized
(CBA   C57BL/6) F1 mouse embryos. Six founder lines were obtained, all
of which showed cell surface expression of the human  1 integrin subunit
on the surface of cells in the epidermal basal layer, outer root sheath, and
periphery of the sebaceous gland. None had a spontaneous skin pheno-
type. The line with the highest  1 integrin expression level (3428B.3) was
selected for further analysis. It was crossed with K14MycER mice (2184C.1;
Arnold and Watt, 2001). Dorsal epidermis was treated with 1 mg/ml
4-OHT, three times per week, and animals were killed after 7 d. In some ex-
periments, mice received two 3- or 5-mm-diam punch biopsy wounds that
were treated with 4-OHT the day after wounding and harvested at day 7.
Online supplemental material
Table S1 shows a summary of results from the microarray experiment.
Videos 1–3 are time-lapse movies documenting the motility of human kera-
tinocytes transduced with either control, MycER, or MycV394DER viruses.
Table S2 shows the primer sequences for RT-PCR and ChIP experiments.
Online supplemental material is available at http://www.jcb.org/content/
full/jcb.200506057/DC1.
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